Theravance Biopharma, Inc.
TBPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,615 | $54,835 | -$13,579 | -$15,527 |
| Dep. & Amort. | $1,407 | $927 | $1,052 | $695 |
| Deferred Tax | $994 | -$10,691 | -$1,852 | -$6,589 |
| Stock-Based Comp. | $0 | $4,543 | $4,877 | $5,826 |
| Change in WC | -$16,880 | $157,796 | $51,937 | $13,887 |
| Other Non-Cash | $4,356 | $664 | $604 | $806 |
| Operating Cash Flow | -$6,508 | $208,074 | $43,039 | -$902 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$34 | $0 | -$190 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$124,746 | -$56,574 | -$1,968 | -$40,013 |
| Inv. Sales/Matur. | $24,500 | $20,350 | $32,600 | $55,889 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$100,246 | -$36,258 | $30,632 | $15,686 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $278 | $0 | $20 | $30 |
| Stock Repurch. | -$678 | -$503 | -$874 | -$528 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $133 |
| Financing Cash Flow | -$400 | -$503 | -$854 | -$365 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$107,154 | $171,313 | $72,817 | $14,419 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $281,927 | $111,450 | $38,633 | $24,214 |
| End Cash | $174,773 | $282,763 | $111,450 | $38,633 |
| Free Cash Flow | -$6,508 | $208,040 | $43,039 | -$1,092 |